TCM
CANC icon

TD Capital Management’s Tema Oncology ETF CANC Stock Holding History

TD Capital Management’s Portfolio CANC Stock Details CANC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5K Hold
376
– – ﹤0.01% 401
2026
Q1 		$13.8K Hold
376
– – ﹤0.01% 428
2025
Q4 		$13.1K Hold
376
– – ﹤0.01% 419
2025
Q3 		$10.8K Buy
+376
New +$9.99K ﹤0.01% 409

Other funds holding CANC

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
PIA
Perennial Investment Advisors Los Angeles, California $1.51B AUM 28.71% 1-Year Est. Return
OIM
Oder Investment Management Woodland Hills, California $149M AUM 20.29% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
WWM
WJ Wealth Management Glendale, Arizona $253M AUM 28.6% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

TD Capital Management's CANC Position: Q2 2026 in Review

TD Capital Management held its Tema Oncology ETF (CANC) position steady in Q2 2026 at 376 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #401.

TD Capital Management first reported a position in CANC in Q3 2025 and has held it in 4 quarters since. 14 funds tracked by Wall St. Rank hold CANC as of Q2 2026.

  • TD Capital Management held 376 shares of Tema Oncology ETF worth $15.5K as of Q2 2026.
  • TD Capital Management left its Tema Oncology ETF share count unchanged in Q2 2026.
  • Tema Oncology ETF made up ﹤0.01% of TD Capital Management's portfolio in Q2 2026, its #401 holding.
  • TD Capital Management first reported a position in Tema Oncology ETF in Q3 2025 and has held it in 4 quarters since.
  • 14 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q2 2026.

Based on TD Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.